SEHA Pioneers Treatment of Rare Immune Disorder with Innovative Therapy
Abu dhabi: SEHA, a subsidiary of PureHealth, has successfully treated a young Emirati woman diagnosed with IgG4-related disease, a rare and complex immune disorder, using the innovative drug Inebilizumab (Uplizna). This achievement marks one of the fi…